BenzingaOctober 20, 2026 at 4:10 AM NY7 Days Ago
Mizuho Maintains Outperform on Cardinal Health, Raises Price Target to $280
Mizuho analyst Steven Valiquette maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $250 to $280.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
